FDA chief Hahn says mid-December vaccine approval just 'possible'


Asked whether the vaccine could become available the week of Dec. 15 after the advisory panel meets, Hahn would not commit. “It is possible. We need everything to fall into place."

NEW YORK: U.S. Food and Drug Administration Commissioner Stephen Hahn said on Tuesday it was "possible" the agency could approve Pfizer Inc's COVID-19 vaccine by mid-December if everything falls into place, but that it may take longer.

When asked in an ABC News interview whether a vaccine could be available days or weeks after a planned Dec. 10 meeting in which FDA expert advisers will recommend for or against approval, Hahn said,"it's hard to predict and I want to set the appropriate expectations."

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Pfizer , Biontech , Covid-19 vaccine , FDA ,

   

Next In Business News

EPF balancing between retirement mandate and supporting members' economic survival
Asian stocks hit by US tech slide, FX subdued
CelcomDigi emphasises its significant role in protecting customers from AI-related risks
China's largest auto show showcases all-electric future, local brands dominate
Unilever beats first quarter sales forecasts, sticks to 2024 outlook
Oil steady as market weighs US demand concerns, Middle East conflict risks
HeiTech Padu targets stronger earnings growth after returning to black in 2023
PBOC may up bond trading
Rafizi: Govt to share details on subsidy rationalisation mechanism
Deutsche Bank Q1 profit jumps 10% as investment bank outperforms

Others Also Read